Skip to main content
. 2014 Dec 5;59(2):205–214. doi: 10.1111/aas.12443

Table 3.

Adverse events, number and percentage of adverse events per 100 patients studied before and after introduction of checklist.

Adverse events Before
After
P value
(n = 801)
(n = 801)
No. % (CI) No. % (CI)
Wound
 Wound infection 57 7.1 (5.3 to 8.9) 48 6.0 (4.3 to 7.6) 0.419
 Wound disruption 38 4.7 (3.3 to 6.2) 52 6.5 (4.8 to 8.2) 0.158
Lung
 Pneumonia 22 2.8 (1.6 to 3.9) 11 1.4 (0.6 to 2.2) 0.077
 Unplanned intubation 8 1.0 (0.3 to 1.7) 5 0.6 (0.1 to 1.2) 0.579
 Pulmonary embolism 1 0.1 (−0.1 to 0.4) 0 1
 Ventilator > 48 h 18 2.2 (1.2 to 3.3) 10 1.2 (0.5 to 2.0) 0.181
Kidney
 Renal insufficiency 4 0.05 (0.0 to 0.1) 1 0.01 (−0.1 to 0.4) 0.374
 Urinary tract infection 17 2.1 (1.1 to 3.1) 14 1.7 (0.8 to 2.7) 0.717
Nervous system
 Stroke/CVA 3 0.04 (0.0 to 0.8) 3 0.04 (0.0 to 0.8) 1
 Coma > 24 h 7 0.09 (0.2 to 0.15) 3 0.4 (0.0 to 0.8) 0.342
 Peripheral nerve injury 0 3 0.4 (0.0 to 0.8) 0.250
Heart and vessels
 Cardiac arrest requiring CPR 1 0.1 (− 0.1 to 0.4) 5 0.6 (0.1 to 1.2) 0.218
 Myocardial infarction 0 1 0.1 (−0.1 to 0.4) 0.317
 Bleeding transfusions > 4 units 12 1.5 (0.6 to 2.3) 14 1.7 (0.8 to 2.7) 0.844
 Thrombophlebitis 4 0.5 (0.0 to 1.0) 3 0.4 (0.0 to 0.8) 1
Sepsis
 Sepsis 16 2.0 (1.0 to 3.0) 4 0.5 (0.0 to 1.0) 0.011
Others
 Reintervention 44 5.5 (3.9 to 7.1) 34 4.4 (0.2 to 1.5) 0.356

CI, confidence interval; CPR, cardiopulmonary resuscitation; CVA, cerebrovascular accident.